Siemens AG, Europe's biggest engineering company, will buy a 16 percent stake in a medical equipment venture with drugmaker Mochida Pharmaceutical Co., giving it a majority holding, Mochida announced Monday.
After the Oct. 1 transaction, Siemens will hold 51 percent of the venture, with the remainder owned by Mochida. The venture has 130 employees and generated revenue of ¥5.6 billion in its last business year. Mochida said the transaction will have little impact on earnings this year.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.